Bio-Path Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.54 | -$1.54 | -$1.54 |
| Q2 2024 | 1 | -$1.02 | -$1.02 | -$1.02 |
| Q3 2024 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q1 2025 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q2 2025 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q3 2025 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q4 2025 | 1 | -$0.40 | -$0.40 | -$0.40 |
Bio-Path Holdings, Inc. Earnings Date And Information
Bio-Path Holdings, Inc. last posted its earnings results on Thursday, August 15th, 2024. The company reported $-1.16 earnings per share for the quarter, topping analysts' consensus estimates of $-1.54 by $0.38. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Bio-Path Holdings, Inc. has generated $-34 earnings per share over the last year ($-33.64 diluted earnings per share) and currently has a price-to-earnings ratio of -0.24. Bio-Path Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 15th, 2024 based on prior year's report dates.
Bio-Path Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.70 | $0 | $0 | ||
| 08/14/2024 | Q2 2024 | -$1.16 | $0 | $0 | ||
| 05/14/2024 | Q1 2024 | -$4.88 | $0 | |||
| 03/07/2024 | Q4 2023 | -$5.46 | $274,000 | |||
| 09/29/2023 | Q3 2023 | -$6.36 | $0 | |||
| 08/14/2023 | Q2 2023 | -$10.64 | $0 | |||
| 05/11/2023 | Q1 2023 | -$13.20 | $0 | |||
| 03/30/2023 | Q4 2022 | -$11.02 | $0 | |||
| 11/14/2022 | Q3 2022 | -$9.84 | $0 | |||
| 08/15/2022 | Q2 2022 | -$10.00 | -$8.40 | 1.6 | $0 | |
| 05/16/2022 | Q1 2022 | -$9.20 | -$9.38 | -0.18 | $0 | |
| 03/10/2022 | Q4 2021 | -$12.24 | $0 | |||
| 11/10/2021 | Q3 2021 | -$6.60 | -$5.88 | 0.72 | $0 | |
| 08/12/2021 | Q2 2021 | -$5.20 | $0 | |||
| 05/13/2021 | Q1 2021 | -$8.55 | $0 | |||
| 03/09/2021 | Q4 2020 | -$13.26 | $0 | |||
| 11/12/2020 | Q3 2020 | -$16.08 | $0 | |||
| 08/13/2020 | Q2 2020 | -$11.05 | $0 | |||
| 05/14/2020 | Q1 2020 | -$18.01 | $0 | |||
| 03/05/2020 | Q4 2019 | -$17.98 | $0 |
Bio-Path Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Bio-Path Holdings, Inc.'s earnings date?
Bio-Path Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 15th, 2024 based off last year's report dates.
-
Did Bio-Path Holdings, Inc. beat their earnings estimates last quarter?
In the previous quarter, Bio-Path Holdings, Inc. (:BPTH) reported $-1.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.54 by $0.38.
-
How can I listen to Bio-Path Holdings, Inc.'s earnings conference call?
The conference call for Bio-Path Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Bio-Path Holdings, Inc.'s conference call transcript?
The conference call transcript for Bio-Path Holdings, Inc.'s latest earnings report can be read online.
-
How much profit does Bio-Path Holdings, Inc. generate each year?
Bio-Path Holdings, Inc. (:BPTH) has a recorded net income of $0. Bio-Path Holdings, Inc. has generated $-33.64 earnings per share over the last four quarters.
-
What is Bio-Path Holdings, Inc.'s price-to-earnings ratio?
Bio-Path Holdings, Inc. (:BPTH) has a price-to-earnings ratio of -0.24 and price/earnings-to-growth ratio is -0.01.
